Article info
PDFSystematic review
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
- Correspondence to Dr Reinout A Bem, Pediatric Intensive Care Unit, Emma Children's Hospital, Amsterdam UMC, location AMC, 1105 AZ Amsterdam, The Netherlands; r.a.bem{at}amsterdamumc.nl
Citation
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
Publication history
- Received August 28, 2020
- Revised September 18, 2020
- Accepted September 29, 2020
- First published October 29, 2020.
Online issue publication
October 18, 2023
Article Versions
- Previous version (22 April 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.